Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis
about
Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treLong-term continuation on cardiovascular drug treatment in patients with coronary heart diseaseCardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort studyStrengths and Limitations of Using the Polypill in Cardiovascular Prevention.Costs and benefits of free medications after myocardial infarction.The UK pay-for-performance programme in primary care: estimation of population mortality reduction.Reasons for not meeting coronary artery disease targets of care in ambulatory practice.Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients.Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.Effect of drug combinations on admission for recurrent myocardial infarctionAssociations between body fat variability and later onset of cardiovascular disease risk factorsScaling up chronic disease prevention interventions in lower- and middle-income countriesEssential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.How many cardiovascular events can be prevented with optimal management of high-risk Canadians?Partnering care delivery and research to optimize health.Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.Imagine how many lives you save: angiotensin-converting enzyme inhibition for atherosclerotic vascular disease in the present era of risk reduction.Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.The polypill: An effective approach to increasing adherence and reducing cardiovascular event risk.The polypill and cardiovascular disease.Drug combinations and all cause mortality in heart disease: no new insights were gained.Drug combinations and all cause mortality in heart disease: use of statins is not supported by study.Drug combinations and all cause mortality in heart disease: dosages and types of ACE inhibitors need to be known.Prescribing practice of general practitioners in Northern Ireland for peripheral arterial disease.Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting.Reduced health care expenditures after enrollment in a collaborative cardiac care service.
P2860
Q28192982-E91C6504-38D3-43B3-A469-B92E5D12FBE4Q28220363-F4CDAE5F-650B-4B25-A6DF-FD5962DEAB15Q28220890-C8A789F0-9535-4B7A-9A56-772F053D8458Q28267175-8151B0D9-9C31-4D52-A979-C73A135C54C4Q33581084-2A919121-8974-4535-893B-3115D1AF4E86Q33585275-35030C59-CACD-41ED-B043-BCB7C55C6D28Q34092301-29D34F91-993F-43AA-A1D5-3EC542EDA2BDQ34121012-E9252471-0758-4067-8887-189BEE99BBC2Q34144971-1700ECB3-1CF7-4283-BF55-B9A76359F0E1Q34313975-F80F8025-0D40-4C02-B687-B54C348FA25DQ35734332-7C308AC8-E93E-426A-B325-32EA8E163929Q35773424-C51C5777-67F9-439A-83F2-984D3D54A3E8Q35902547-1A8ADA48-E811-45CC-9A0B-C194ED3D5D12Q36025762-0D5CDCFD-89B3-4685-B140-AE71867A79F2Q36331973-ED65BD2B-7858-4092-A15D-4FE11CA95C75Q36939475-4C23C607-6341-4A71-8082-FB9F30E3D298Q36957089-B2B6A91B-2C0B-4CD9-9384-81620F1958CDQ37098243-4DF8D6CE-3A62-439D-BC3E-5FE0AAFC8500Q37161966-02ABE82F-2B14-45F9-BC37-512FD77C9555Q37292366-495DA72D-BC11-4D9F-A570-FA8B70A3A0E1Q37846720-0637047F-3730-4F8D-A0EF-001609F03051Q38011618-6F014EE1-3F76-420C-BEF6-3CC8E9F395D9Q39231217-6A415D77-D2AC-40BF-AFB9-AB557D9A9A24Q43045345-8ECC2FE2-96F1-4989-B271-1353F16E8A4AQ43069105-2570914B-247C-4B00-AF3B-84111C3CA352Q43069534-E338D71E-A18A-4990-A055-6FCF223C7040Q43069553-70FBB7BA-80AB-450F-A3C0-B1E4360C073DQ46719220-22C5FD7E-1A5F-4BDA-AAC4-E05729BE66DAQ46880764-51F78361-91B2-415B-B05B-FF0EED603AAEQ46981071-8FA61FC5-B81F-4129-91F0-D130ECEC8EDAQ50217749-7354E8DF-A341-40D3-921B-027704F65237Q51535949-A5812084-972D-442B-B98A-349C5E9CDB71
P2860
Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of combinations of drug ...... : nested case-control analysis
@ast
Effect of combinations of drug ...... : nested case-control analysis
@en
Effect of combinations of drug ...... : nested case-control analysis
@nl
type
label
Effect of combinations of drug ...... : nested case-control analysis
@ast
Effect of combinations of drug ...... : nested case-control analysis
@en
Effect of combinations of drug ...... : nested case-control analysis
@nl
prefLabel
Effect of combinations of drug ...... : nested case-control analysis
@ast
Effect of combinations of drug ...... : nested case-control analysis
@en
Effect of combinations of drug ...... : nested case-control analysis
@nl
P2860
P1433
P1476
Effect of combinations of drug ...... : nested case-control analysis
@en
P2093
Carol Coupland
P2860
P304
P356
10.1136/BMJ.330.7499.1059
P407
P577
2005-05-07T00:00:00Z